Kancera AB (OSTO:KAN) Accumulated Depreciation : kr0.00 Mil (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Kancera AB Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Kancera AB's annual accumulated depreciation increased from Dec. 2021 (kr-0.50 Mil) to Dec. 2022 (kr-0.86 Mil) but then stayed the same from Dec. 2022 (kr-0.86 Mil) to Dec. 2023 (kr0.00 Mil).

Kancera AB Accumulated Depreciation Historical Data

The historical data trend for Kancera AB's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kancera AB Accumulated Depreciation Chart

Kancera AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-7.77

-0.18

-0.50

-0.86

Kancera AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-	-

Kancera AB Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Kancera AB Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Kancera AB's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kancera AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kancera AB (OSTO:KAN) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

3EE0:Germany

Address

Karolinska Institutet Science Park, Banvaktsvagen 22, Solna, SWE, 171 48

Website

http://www.kancera.com

Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.

Kancera AB Headlines

No Headlines